Article
Biological activity of a genetically modified BMP-2 variant with inhibitory activity.
Head & face medicine - 2 Feb 2009
Klammert Uwe, Nickel Joachim, Würzler Kristian, Klingelhöffer Christoph, Sebald Walter, Kübler Alexander C, Reuther Tobias
Abstract excerpt
BACKGROUND: Alterations of the binding epitopes of bone morphogenetic protein-2 (BMP-2) lead to a modified interaction with the ectodomains of BMP receptors. In the present study the biological effect of a BMP-2 double mutant with antagonistic activity was evaluated in vivo. METHODS: Equine-derived collagenous carriers were loaded with recombinant human BMP-2 (rhBMP-2) in a well-known dose to provide an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
